Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
NYSE MKT COMPOSITE
Impressive Trial Results For Gilead
MarketMinute.com Stock News
Gilead Sciences Inc. (
) reported impressive results from a mid-stage trial using a combination of sofosbuvir, ribavirin and GS-5885 to treat hepatitis C sending the stock price soaring $7.55 to $72.56.
Gilead Sciences, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here